LACTB and infection: While these organizations cannot promote specific commercial tests, they should promote the concept of detecting CPOs as early as possible in the course of infection and differentiating among enzyme classes to ensure the prudent use of the newer beta-lactam/beta-lactamase inhibitor combinations and enhance antimicrobial stewardship efforts globally.